Allergan (AGN): Cutting PT To $280 From $400 - Cowen

October 20, 2017 7:05 AM EDT Send to a Friend
Cowen analyst, Ken Cacciatore, reiterated his Outperform rating on shares of Allergen (NYSE: AGN) but cut his price target to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login